Antibodies : Engineering and Therapeutics

  • Therapeutic Abs come from critical screenings of in vivo and in vitromethods
  • Bispecific Abs increase specificity and broaden the range of therapeutic MOA.
  • Optimized Ab leads undergo HFA, affinity maturation, and developability assessment.
  • Fc optimization is critical for antibody pharmacokinetics and pharmacodynamics

Related Conference of Antibodies : Engineering and Therapeutics

October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan
December 06-07, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

Baltimore, USA
May 20-21, 2019

35th World Vaccines & Immunization Congress

Tokyo, Japan

Antibodies : Engineering and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in